NJBEST
HZNP

New Jersey Better Educational Savings Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,900
Closed -$220K – 94
2023
Q3 		$220K Buy
+1,900
New +$204K 0.54% 64

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New Jersey Better Educational Savings Trust's HZNP Position: Q4 2023 in Review

New Jersey Better Educational Savings Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,900 shares — an estimated $220K sold.

New Jersey Better Educational Savings Trust first reported a position in HZNP in Q3 2023 and held it in 1 quarter. The position peaked at $220K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • New Jersey Better Educational Savings Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • New Jersey Better Educational Savings Trust sold 1,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $220K.
  • New Jersey Better Educational Savings Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • New Jersey Better Educational Savings Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $220K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q4 2023, filed 2 Feb 2024.